Pharmacielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more
Pharmacielo Ltd (PCLOF) - Total Liabilities
Latest total liabilities as of September 2025: $16.93 Million USD
Based on the latest financial reports, Pharmacielo Ltd (PCLOF) has total liabilities worth $16.93 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmacielo Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how Pharmacielo Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmacielo Ltd Competitors by Total Liabilities
The table below lists competitors of Pharmacielo Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GUH Holdings Bhd
KLSE:3247
|
Malaysia | RM237.08 Million |
|
PROEN Corp Public Company Limited
BK:PROEN
|
Thailand | ฿729.50 Million |
|
Vacasa Inc
NASDAQ:VCSA
|
USA | $468.78 Million |
|
Parks! America Inc
PINK:PRKA
|
USA | $4.56 Million |
|
CopAur Minerals Inc
OTCQX:COPAF
|
USA | $182.98K |
|
Perfect Moment Ltd.
NASDAQ:PMNT
|
USA | $13.98 Million |
|
Begistics Public Company Limited
BK:B
|
Thailand | ฿1.92 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Pharmacielo Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmacielo Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmacielo Ltd (2015–2024)
The table below shows the annual total liabilities of Pharmacielo Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $25.91 Million | +8.10% |
| 2023-12-31 | $23.97 Million | +28.01% |
| 2022-12-31 | $18.72 Million | +12.58% |
| 2021-12-31 | $16.63 Million | -6.45% |
| 2020-12-31 | $17.78 Million | +275.76% |
| 2019-12-31 | $4.73 Million | +20779.39% |
| 2018-12-31 | $22.66K | +79.19% |
| 2017-12-31 | $12.64K | -99.41% |
| 2016-12-31 | $2.15 Million | +1081.44% |
| 2015-12-31 | $182.03K | -- |